Forbes contributors publish independent expert analyses and insights. Expert in AI for healthcare and longevity biotechnology Sep 27, 2023, 12:53pm EDT This article is more than 2 years old. The ...

Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...

D&D Pharmatech has secured $51 million to fund clinical development across its five subsidiaries, including phase 2 trials in fatty liver disease, Parkinson's and Alzheimer's. The series C, originally ...

In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis and tuberculosis. Less visibly, AbbVie shuttered last ...

Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today announced the successful closing of a ...

There are quite a few surprising and meaningful parallels between the agricultural and pharmaceutical chemistry fields, especially when it comes to how they approach research and development, ...

Pharmacists deliver life-changing healthcare. Their compassionate guidance educates patients on how to make the safest and best use of their prescribed medications. The University of Wyoming School of ...

SALZBURG, Austria--(BUSINESS WIRE)--After successfully launching the D-mine ® Pump, an infusion device designed to provide precise continuous subcutaneous drug delivery for Parkinson´s patients, EVER ...